Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.
about
Frontline Dasatinib Treatment in a "Real-Life" Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia.First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.Evaluation and reporting of quality of life outcomes in phase III chemotherapy trials for poor prognosis malignancies.Cancer in a gerontological context.Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hematological malignancy.Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment?Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force.A Formative Qualitative Evaluation to Inform Implementation of a Research Participation Enhancement and Advocacy Training Program for Diverse Seniors: The DREAMS Program.Comorbidity, Physical Function, and Quality of Life in Older Adults with Acute Myeloid Leukemia.Incidence and survival of hematological cancers among adults ages ≥75 years.Selection of Patients in Ongoing Clinical Trials on Lung Cancer.
P2860
Q37273788-3C7792C7-1CA6-42BC-9106-D704E79798F8Q38791698-AD1B2F19-7C79-46B8-B804-1380073CFF73Q39629391-0DB90761-6219-47CD-85B3-7FEE39F93B3CQ42697233-073D81AF-508B-4155-9072-5FDF66EFFB86Q47835222-E765C2A1-63F9-46D3-8232-22B320833306Q47869630-34F47DA4-F130-4FB8-B5B7-F0C5078A190EQ48206720-83F16AFD-AD61-4FC8-8FEA-06D328EC04A6Q48751476-F7255194-3BF8-4F07-BF73-CB44591824ABQ49817989-C9D8DFEB-7CFF-4F8A-9C12-89EB909F8850Q50234387-473BC810-814A-4509-A44F-728B82CF85F0Q54342150-F46FC8B7-6B09-4A51-B866-2E70632169D1Q54422507-ADCBC762-12C3-496E-BF02-C43177884D8F
P2860
Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Exclusion of older patients fr ...... ealth Clinical Trial Registry.
@ast
Exclusion of older patients fr ...... ealth Clinical Trial Registry.
@en
Exclusion of older patients fr ...... ealth Clinical Trial Registry.
@nl
type
label
Exclusion of older patients fr ...... ealth Clinical Trial Registry.
@ast
Exclusion of older patients fr ...... ealth Clinical Trial Registry.
@en
Exclusion of older patients fr ...... ealth Clinical Trial Registry.
@nl
prefLabel
Exclusion of older patients fr ...... ealth Clinical Trial Registry.
@ast
Exclusion of older patients fr ...... ealth Clinical Trial Registry.
@en
Exclusion of older patients fr ...... ealth Clinical Trial Registry.
@nl
P2093
P2860
P1433
P1476
Exclusion of older patients fr ...... ealth Clinical Trial Registry.
@en
P2093
Barbara C van Munster
Marije E Hamaker
Reinhard Stauder
P2860
P304
P356
10.1634/THEONCOLOGIST.2014-0093
P577
2014-08-28T00:00:00Z